Ann Lab Med.
2015 Nov;35(6):651-653. 10.3343/alm.2015.35.6.651.
Straightforward Identification of Masked Polycythemia Vera Based on Proposed Revision of World Health Organization Diagnostic Criteria for BCR-ABL1-Negative Myeloproliferative Neoplasms
- Affiliations
-
- 1Department of Laboratory Medicine, University of Ulsan, College of Medicine and Asan Medical Center, Seoul, Korea. yucho@amc.seoul.kr
- KMID: 2363272
- DOI: http://doi.org/10.3343/alm.2015.35.6.651
Abstract
- No abstract available.
MeSH Terms
-
Adult
Biomarkers, Tumor/genetics
Bone Marrow/pathology
Calreticulin/genetics
Erythropoietin/blood
Female
Fusion Proteins, bcr-abl/*genetics
Hematocrit
Hemoglobins/analysis
Humans
Janus Kinase 2/genetics
Male
Middle Aged
Mutation
Myeloproliferative Disorders/*diagnosis/genetics
Polycythemia Vera/*diagnosis/genetics
Receptors, Thrombopoietin/genetics
Thrombocythemia, Essential/diagnosis
World Health Organization
Biomarkers, Tumor
Calreticulin
Erythropoietin
Fusion Proteins, bcr-abl
Hemoglobins
Janus Kinase 2
Receptors, Thrombopoietin
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Major Changes to the 2017 Revision of the World Health Organization Classification of Myeloproliferative Neoplasms
- Advances in the Diagnosis of Myeloproliferative Neoplasms
- JAK2 V617F and the evolving paradigm of polycythemia vera
- GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms
- Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study
